Valuation: IDEXX Laboratories, Inc.

Market Cap 43.42B 38.77B 35.58B 32.36B 60.68B 4,111B 61.88B 425B 171B 2,170B 163B 160B 6,854B P/E 2026 *
45.1x
P/E 2027 * 40.3x
Enterprise Value 43.79B 39.1B 35.88B 32.64B 61.19B 4,146B 62.41B 429B 173B 2,188B 164B 161B 6,912B EV / Sales 2026 *
9.26x
EV / Sales 2027 * 8.42x
Free-Float
72.37%
Yield 2026 *
-
Yield 2027 * -
1 day+21.85%
1 week+17.79%
Current month+21.85%
1 month+29.56%
3 months+20.14%
6 months+18.36%
Current year-0.72%
1 week 540.61
Extreme 540.61
673.19
1 month 501.17
Extreme 501.17
673.19
Current year 500.61
Extreme 500.61
726.41
1 year 500.61
Extreme 500.61
769.98
3 years 356.14
Extreme 356.14
769.98
5 years 317.06
Extreme 317.06
769.98
10 years 104.21
Extreme 104.211
769.98
Manager TitleAgeSince
Chief Executive Officer 52 2026-05-11
Director of Finance/CFO 43 2025-02-28
Chief Operating Officer 58 2024-12-31
Director TitleAgeSince
Chairman 65 2026-05-11
Director/Board Member 64 2013-07-14
Director/Board Member 73 2014-03-10
Date Insider Type Main position Quantity % Market Cap. Importance
9/4/26 Exercice

Director

6,609 0.0084%
8/20/26 Exercice

Chief Financial Officer

616 0.0008%
7/30/26 Free

Director

49 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+21.85%+17.79%+6.69%+60.13% 43.42B
+3.73%+5.03%-10.89%+14.80% 184B
+2.85%+4.75%+9.47%+37.73% 118B
+5.12%+0.22%-13.88%+10.27% 111B
+1.41%+6.80%-41.10%+6.45% 94.58B
+2.12%+2.38%+0.01%+75.79% 63.13B
-5.48%-5.11%-1.24%+61.88% 55.66B
+0.36%+1.13%+11.13%-22.40% 53.9B
+2.23%+4.24%+1.04%-8.32% 34.68B
+3.00%+7.88%+45.59%-9.51% 30.69B
Average +3.72%+4.60%+0.68%+22.68% 78.91B
Weighted average by Cap. +3.41%+4.20%-5.14%+22.79%

Financials

2026 *2027 *
Net sales 4.73B 4.22B 3.87B 3.52B 6.61B 448B 6.74B 46.27B 18.65B 236B 17.75B 17.37B 746B 5.15B 4.59B 4.22B 3.84B 7.19B 487B 7.33B 50.36B 20.3B 257B 19.32B 18.9B 812B
Net income 1.18B 1.05B 968M 880M 1.65B 112B 1.68B 11.56B 4.66B 59.03B 4.43B 4.34B 186B 1.31B 1.17B 1.07B 976M 1.83B 124B 1.87B 12.82B 5.17B 65.45B 4.92B 4.81B 207B
Net Debt 368M 328M 301M 274M 514M 34.8B 524M 3.6B 1.45B 18.37B 1.38B 1.35B 58.01B -98.49M -87.93M -80.69M -73.4M -138M -9.32B -140M -964M -388M -4.92B -370M -362M -15.54B
Projected Income Statement - Annual - IDEXX Laboratories, Inc.
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change Volume
26-11-02 US$671.64 +21.85% 1,977,101
26-10-30 US$551.21 -4.30% 1,174,194
26-10-29 US$575.98 +2.32% 479,539
26-10-28 US$562.91 +0.30% 351,839
26-10-27 US$561.25 -1.57% 488,986
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - IDEXX Laboratories, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
671.64USD
Average target price
694.42USD
Spread / Average Target
+3.39%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - IDEXX Laboratories, Inc.
  1. Stock Market
  2. Stocks
  3. IDXX Stock